Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II

No abstract is available for this paper.

• Publication year

  2000

• Venue

  International journal of impotence research

• Publication date

  2000-09-27

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/sj.ijir.3900582PMID 11035391
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction.

  2000cited by this paper
• Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: Double-blind placebo controlled crossover study

  1999cited by this paper
• Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study.

  1998cited by this paper
• Differential influence of a selective melanocortin MC4 receptor antagonist (HS014) on melanocortin-induced behavioral effects in rats.

  1998cited by this paper
• Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands.

  1998cited by this paper
• The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

  1997cited by this paper
• Role of melanocortinergic neurons in feeding and the agouti obesity syndrome

  1997cited by this paper
• Skin Pigmentation and Pharmacokinetics of Melanotan‐I in Humans

  1997cited by this paper
• Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study.

  1996cited by this paper
• Molecular cloning of a novel melanocortin receptor.

  1993cited by this paper
• NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence.

  1993cited by this paper
• The cloning of a family of genes that encode the melanocortin receptors.

  1992cited by this paper
• Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA

  1992cited by this paper
• Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin.

  1991cited by this paper
• Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics.

  1989cited by this paper
• Yawning and Penile Erection: Central Dopamine‐Oxytocin‐Adrenocorticotropin Connection a

  1988cited by this paper
• Facilitation and inhibition of sexual receptivity in the female rat by alpha-MSH.

  1979cited by this paper
• Induction of Sexual Excitement by the Action of Adrenocorticotrophic Hormone in Brain

  1969cited by this paper

• Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report.

  2026cites this paper
• Evolving medical management of erectile dysfunction: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024).

  2025cites this paper
• The effectiveness of electrical stimulation in the treatment of erectile dysfunction: a systematic review of randomized controlled trials

  2025cites this paper
• The hormonal regulation of men's sexual desire, arousal, and penile erection: recommendations from the fifth international consultation on sexual medicine (ICSM 2024).

  2025cites this paper
• Pathogenesis and treatment of diabetes mellitus-related erectile dysfunction: current therapies and potential challenges

  2024cites this paper
• An overview of benefits and risks of chronic melanocortin‐1 receptor activation

  2024cites this paper
• Melanocortin 1 Receptor (MC1R): Pharmacological and Therapeutic Aspects

  2023cites this paper
• A review on pharmacological options for the treatment of erectile dysfunction: state of the art and new strategies

  2023cites this paper
• Comprehensive Perspectives for Erectile Dysfunction Pharmacotherapy: from Mechanism to Application.

  2022cites this paper
• Pharmacology and perspectives in erectile dysfunction in man.

  2020cites this paper
• Therapeutic Strategies for Erectile Dysfunction With Emphasis on Recent Approaches in Nanomedicine

  2020cites this paper
• Mesoporous polymer network produced from N-vinylpyrrolidone and triethylene glycol dimethacrylate as potential macromolecularly imprinted material and oligopeptide carrier

  2020cites this paper
• Multidisciplinary Approach to Treat Erectile Dysfunction

  2020cites this paper
• LC-HRMS characterization of the skin pigmentation and sexual enhancers melanotan II and bremelanotide sold on the black market of PIEDs.

  2020cites this paper
• Genetics and erectile dysfunction: leveraging early foundations for new discoveries

  2020cites this paper
• Drug delivery options and therapeutic advances in the management of erectile dysfunction

  2020cites this paper
• Novel insights into the metabolic action of Kiss1 neurons

  2020cites this paper
• Novel Emerging Therapies for Erectile Dysfunction

  2020cites this paper
• Hindbrain melanocortin 3/4 receptors modulate the food intake and body weight suppressive effects of the GLP-1 receptor agonist, liraglutide.

  2020cites this paper
• Melanotan II: a possible cause of renal infarction: review of the literature and case report

  2020cites this paper
• Oxytocin Neurons Enable Melanocortin Regulation of Male Sexual Function in Mice

  2019cites this paper
• Emerging Treatments for Erectile Dysfunction: a Review of Novel, Non-surgical Options

  2019cites this paper
• A Review of Genome Wide Association Studies for Erectile Dysfunction

  2019cites this paper
• Understanding melanocortin-4 receptor control of neuronal circuits: Toward novel therapeutics for obesity syndrome.

  2018cites this paper
• Sim1 Neurons Are Sufficient for MC4R-Mediated Sexual Function in Male Mice

  2018cites this paper
• Sex and Pharmacological Sexual Enhancement

  2017cites this paper
• Menopause-Andropause-Anti-Aging 2010. 9.-11. Dezember 2010, Wien Abstracts

  2017cites this paper
• Treatment of Erectile Disorder

  2017cites this paper
• Drugs in preclinical to phase II clinical development for the treatment of erectile dysfunction

  2017cites this paper
• Research in pharmacotherapy for erectile dysfunction

  2017cites this paper
• Design of cyclic peptides with biological activities from biologically active peptides: the case of peptide modulators of melanocortin receptors

  2016cites this paper
• Future Targets for Female Sexual Dysfunction.

  2016cites this paper
• Synthesis and Structure-Activity Relationships of Substituted Urea Derivatives on Mouse Melanocortin Receptors.

  2016cites this paper
• The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases.

  2016cites this paper
• Advances in the treatment of erectile dysfunction: what’s new and upcoming?

  2016cites this paper
• Drug therapy for erectile dysfunction

  2016cites this paper
• Pharmacotherapeutic management of erectile dysfunction

  2015cites this paper
• Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet.

  2015cites this paper
• Emerging drugs for the treatment of erectile dysfunction

  2015cites this paper
• Melanocortin Receptor Agonists Facilitate Oxytocin-Dependent Partner Preference Formation in the Prairie Vole

  2015cites this paper
• An in-depth case examination of an exotic dancer's experience of melanotan.

  2014cites this paper
• An unhealthy glow? A review of melanotan use and associated clinical outcomes

  2014cites this paper
• Melanocortin receptor agonists in the treatment of male and female sexual dysfunctions: results from basic research and clinical studies

  2014cites this paper
• SMART: An Internet study of users experiences of synthetic tanning

  2014cites this paper
• Synthesis, Biophysical, and Pharmacological Evaluation of the Melanocortin Agonist AST3-88: Modifications of Peptide Backbone at Trp 7 Position Lead to a Potent, Selective, and Stable Ligand of the Melanocortin 4 Receptor (MC4R)

  2014cites this paper
• Afamelanotide for the treatment of erythropoietic protoporphyria

  2013cites this paper
• Heuristics of human enhancement risk: a little chemical help?

  2013cites this paper
• Discrete melanocortin-sensitive neuroanatomical pathway linking the ventral premmamillary nucleus to the paraventricular hypothalamus.

  2013cites this paper
• Evaluation and Management of Erectile Dysfunction

  2012cites this paper
• Optimized purification and characterization of expressed hMC4R-TM2

  2012cites this paper
• Effects of leptin and melanocortin signaling interactions on pubertal development and reproduction.

  2012cites this paper
• Melanotan II 3 " Melanotan " products sold for human use

  2012cites this paper
• Normal Erectile Physiology

  2011cites this paper
• Mechanisms of Penile Erection and Basis for Pharmacological Treatment of Erectile Dysfunction

  2011cites this paper
• Emerging and Novel Therapeutic Approaches in the Treatment of Male Erectile Dysfunction

  2011cites this paper
• Multiple N-methylation of MT-II backbone amide bonds leads to melanocortin receptor subtype hMC1R selectivity: pharmacological and conformational studies.

  2010cites this paper
• Anatomy, physiology, and pathophysiology of erectile dysfunction.

  2010cites this paper
• Discovery of a selective small-molecule melanocortin-4 receptor agonist with efficacy in a pilot study of sexual dysfunction in humans.

  2010cites this paper
• Organic chemistry and biology: chemical biology through the eyes of collaboration.

  2009cites this paper
• Diagnosis and treatment of erectile dysfunction– a practical update

  2009cites this paper
• Phosphodiesterase 5 inhibitors and erectile dysfunction

  2008cites this paper
• Pharmacologic Treatment of Obesity: Pitfalls and New Promises

  2008cites this paper
• Pharmacokinetic studies for the development of transdermal drug delivery systems

  2007cites this paper
• Effects of pro-opiomelanocortin (POMC) on food intake and body weight: mechanisms and therapeutic potential?

  2007cites this paper
• The future of the oral pharmacotherapy of male erectile dysfunction: things to come

  2007cites this paper
• Melanocortin-4 receptor agonists for the treatment of obesity.

  2007cites this paper
• [Sexuality and pharmacotherapy. Medication-induced disorders of sexual response and pharmacotherapeutic options for the treatment of sexual dysfunctions].

  2007cites this paper
• Neuroprotective effects of melanocortins in CNS injury.

  2007cites this paper
• Sexualität und Pharmakotherapie

  2007influential citation
• The Psychophysiology of Sex

  2007cites this paper
• MC4R oligomerizes independently of extracellular cysteine residues.

  2006cites this paper
• Existing and future pharmacotherapy for erectile dysfunction

  2006cites this paper
• The melanocortin peptide HP228 displays protective effects in acute models of inflammation and organ damage.

  2006cites this paper
• Obesity drugs and their targets: correlation of mouse knockout phenotypes with drug effects in vivo

  2006cites this paper
• Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization.

  2006cites this paper
• Targeting melanocortin receptors as potential novel therapeutics.

  2006cites this paper
• Melanocortin receptors and energy homeostasis

  2005cites this paper
• Discovery that a melanocortin regulates sexual functions in male and female humans.

  2005cites this paper
• The supraspinal network in the control of erection

  2005cites this paper
• Central Activation of Erection and Clinical Experience

  2005cites this paper
• Strategies in the oral pharmacotherapy of male erectile dysfunction viewed from bench and bedside (Part II)

  2005cites this paper
• Feeding effects of melanocortin ligands--a historical perspective.

  2005cites this paper
• Gene polymorphisms and their effects in the melanocortin system.

  2005cites this paper
• Discovery of (2S)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-4-methyl-2-piperazinecarboxamide (MB243), a potent and selective melanocortin subtype-4 receptor agonist.

  2005cites this paper
• Melanocortins in sexual function

  2004cites this paper
• Pharmacotherapy of Sexual Dysfunctions : Current Status

  2004cites this paper
• Melanocortin receptors and erectile function.

  2004cites this paper
• Therapy of erectile dysfunction

  2004cites this paper
• Erectile dysfunction: Expectations beyond phosphodiesterase Type 5 inhibition

  2004cites this paper
• Novel agents for sexual dysfunction

  2003cites this paper
• Early diagnosis and treatment of endocrine disorders

  2003influential citation
• The melanocortin system and its role in obesity and cachexia.

  2003cites this paper
• Synthesis of 2,4,5-trisubstituted tetrahydropyrans as peptidomimetic scaffolds for melanocortin receptor ligands.

  2003cites this paper
• Novel tetrahydropyran-based peptidomimetics from a bioisosteric transformation of a tripeptide. Evidence of their activity at melanocortin receptors.

  2003cites this paper
• Current and future trends in the oral pharmacotherapy of male erectile dysfunction

  2003cites this paper
• [Therapy of erectile dysfunction in 2005].

  2003cites this paper
• Early Diagnosis and Treatment of Endocrine Disorders

  2003cites this paper
• Therapie der erektilen Dysfunktion im Jahr 2005

  2003cites this paper
• Agonist-Dependent Internalization of the Human Melanocortin-4 Receptors in Human Embryonic Kidney 293 Cells

  2003cites this paper
• Assessment of the aversive consequences of acute and chronic administration of the melanocortin agonist, MTII

  2003cites this paper